Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Overview - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 171091
Later capture
Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Overview - Canada.ca
Jan 2, 2026
hc-20260101
ID 429091
updated1 sections changed
1 sections changed0 added0 removed+0 / -1 linesChange ratio: 0%
--- +++ @@ -135,5 +135,4 @@ As always, Health Canada reserves the right to request information or material, or define conditions not specifically described in this document, to help us adequately assess the safety, efficacy or quality of a therapeutic product. We must make sure that such requests are justifiable and that decisions are clearly documented. This document should be read in conjunction with the accompanying notice and the relevant sections of other applicable guidance documents. Page details-Date modified: 2022-12-16